Photo: Letters the Vaccination will receive 200 volunteers
In the first phase of testing will be vaccinated 200 healthy participants aged 18 to 55 years.
In Germany, issued the first permission for clinical testing of a vaccine against coronavirus COVID-19. On Wednesday, April 22, reports Interfax-Ukraine with reference to the press service of the German Federal Institute for vaccines and biomedical drugs PEI.
“The resolution is the result of a careful assessment of the potential risks and benefits of the candidate for testing”, – stated in the message.
It is noted that the test vaccine produced by the company from Mainz Biontech, now she can test it on volunteers.
“In the first part of the allowed clinical testing will be vaccinated 200 healthy participants aged 18 to 55 years,” reports the Institute.
The report said that Biontech has developed RNA vaccine, which contains genetic information in the form of RNA.
Earlier it was reported that Britain has begun mass production of a potential vaccine against COVID-19. The vaccine has not yet passed clinical trials, but in Britain, by September we plan to make a million doses.
We will remind, the UN adopted a resolution about the accessibility of vaccines from COVID-19, which contains the appeal not to allow speculation on future vaccine against coronavirus COVID-19.